The Clinical and Economic Value of Continuous Glucose Monitoring and Improved Time in Range

Webinar Recorded on Feb. 13, 2020 
Sponsored by Dexcom 

Download Presentation

Advances in continuous glucose monitoring (CGM) technology have allowed for improved glycemic management through the use of emerging metrics such as time in range (TIR). Using CGM-based metrics as tools for glycemic management are expected to reduce complications and associated costs.

Join expert faculty as they discuss:

• Limitations of HbA1c for assessing glycemic control
• Relationship between TIR, HbA1c, and the development of microvascular complications
• The value of TIR as a tool for individual glycemic management
• Standardized CGM metrics and targets for selected patient populations
• Retrospective analysis of CGM data using the Ambulatory Glucose Profile (AGP) standardized report
• Use of Dexcom G6® real-time, interoperable CGM to optimize TIR
• Health and economic benefits associated with improved TIR at the population level

Expert Faculty:  

Nicholas B. Argento, MD
Endocrinologist
Maryland Endocrine and Diabetes
Diabetes Technology Director
Columbia, MD

Dhiren K. Patel, PharmD, CDE, BC-ADM, BCACP
Adjunct Associate Professor of Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Clinical Pharmacy Specialist
VA Boston Healthcare System
Boston, MA
 

This webinar is sponsored, developed and presented by the sponsor. The content of this Science & Innovation Theater Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP. 

Sponsored by: